Medtech stories we missed this week: June 8, 2018

Share

missed-medtech-0323

[Image from unsplash.com]

From Royal Philips receiving FDA clearance to NeuroPace launching its epilepsy treatment device, here are seven medtech stories we missed this week but thought were still worth mentioning.

1. FDA clears Philips’s Ingenia Elition 3.0T MR scanner

Royal Philips announced in a June 5 press release that it has received FDA 510(k) clearance for its Ingenia Elition 3.0T MR solution and its two clinical applications Philips Compressed Sense and 3D APT. The products help clinicians perform exams up to 50% faster while increasing diagnostic confidence and improving patient experience.

2. Pentax to distribute CapsoCam Plus

Pentax has entered an exclusive distribution agreement with CapsoVision in the U.S. to distribute the CapsoCam Plus Capsule Endoscopy line of products, according to a June 4 press release. Under the agreement, Pentax will serve as the U.S. sales agent for the CapsoCam Plus System, including CapsoCloud and CapsoView. The CapsoCam Plus System is a user-friendly capsule endoscopy solution that has a full 360º image of the small bowel mucosa. Its panoramic lateral view camera is designed to improve diagnostic confidence by overcoming field of view limitations that comes with end-facing cameras.

3. Cook Medical to distribute Taewoon Medical’s GI stents

Cook Medical and Taewoon Medical announced in a June 4 press release that Cook Medical will distribute Taewoon Medical’s stents throughout the U.S. The agreement includes the company’s Niti-S Through the Scope (TTS) Esophageal Stent. Cook Medical will begin distributing the stents on Nov. 1 this year. The Niti-S TTS Esophageal Stent is preloaded in a 10.5 Fr delivery system. The scope can then be delivered with a conical tip that is designed to navigate tight structures and tortuous anatomies.

Get the full story on our sister site, MassDevice.

Inside Hologic's evolving definition of women's healthcare

textadimage Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.

At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!

REGISTER NOW

Use code WOMENSHEALTH to save an additional 10%.

Speak Your Mind

*